Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In Despite the lack of investment in innovation, the existence of a network of public laboratories is an important strength of the country, often the only way to produce medicines for diseases of poverty (Garcia, 2011). Proof of this is a notable Brazilian path towards self-sufficiency in the production of vaccines by public laboratories initially motivated by the lack of continuity of private production and the lack of interest of the market in these products (Raw & Higashi, 2008). Technological park modernization programs, as well as investment in productive development partnerships, are pointed out as strategies to strengthen the production of medicines for diseases of poverty, despite the lower participation of these drugs in the portfolio of official laboratories (Magalhães, 2010;Oliveira et al, 2006;Resende, 2013).…”
Section: Research Development and Production Of Pharmaceuticals: Right Denied By The Marketmentioning
confidence: 99%
See 1 more Smart Citation
“…In Despite the lack of investment in innovation, the existence of a network of public laboratories is an important strength of the country, often the only way to produce medicines for diseases of poverty (Garcia, 2011). Proof of this is a notable Brazilian path towards self-sufficiency in the production of vaccines by public laboratories initially motivated by the lack of continuity of private production and the lack of interest of the market in these products (Raw & Higashi, 2008). Technological park modernization programs, as well as investment in productive development partnerships, are pointed out as strategies to strengthen the production of medicines for diseases of poverty, despite the lower participation of these drugs in the portfolio of official laboratories (Magalhães, 2010;Oliveira et al, 2006;Resende, 2013).…”
Section: Research Development and Production Of Pharmaceuticals: Right Denied By The Marketmentioning
confidence: 99%
“…The cost-effectiveness of these medicines is explained by the involvement of official public laboratories that account for more than 80% of the production of medicines for diseases of poverty. In 1992, for example, approximately 60% of all PNI vaccines were imported; in 2002, 70% were produced in Brazil and in 2012 almost 96% were already produced in the country and a large part by public laboratories of the Oswaldo Cruz Foundation and Instituto Butantan (Barreto et al, 2011;Domingues & Teixeira, 2013;Raw & Higashi, 2008).…”
Section: Offer Of Available Therapies: Guaranteed Right?mentioning
confidence: 99%